Last updated: May 29, 2026

Application No. 18/026,568

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS WITH DOUBLE AND TRIPLE COMBINATIONS OF ANTIVIRAL AND IMMUNE MODULATING COMPOUNDS

Final Rejection

Filed

Mar 15, 2023

Priority

Sep 17, 2020 — provisional 63/079,849 +7 more

Examiner

LEWIS, PATRICK T

Art Unit

1691

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Iaterion Inc.

OA Round

2 (Final)

Interview Optional

— +14.5% interview lift. Interview lift (+14.5%) is below the 15.0% threshold. A written response is recommended.

Based on 1146 resolved cases, 2023–2026

Examiner Intelligence

LEWIS, PATRICK T View full profile →

Grants 74% — above average

Career Allowance Rate

851 granted / 1146 resolved

+14.3% vs TC avg

Moderate +14% lift

Without

With

+14.5%

Interview Lift

resolved cases with interview

Typical timeline

2y 3m

Avg Prosecution

25 currently pending

Career history

1176

Total Applications

across all art units

Statute-Specific Performance

§101

2.2%

-37.8% vs TC avg

§103

55.8%

+15.8% vs TC avg

§102

19.4%

-20.6% vs TC avg

§112

12.5%

-27.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1146 resolved cases

Prosecution Timeline

Mar 15, 2023

Application Filed

Aug 22, 2025

Non-Final Rejection mailed

Nov 24, 2025

Response Filed

Jan 30, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/125,335

Patent 12636305

COMPOSITION AND METHOD OF APPLYING SAME TO INCREASE SURVIVAL OF FISH FOLLOWING CATCH-AND-RELEASE SITUATIONS

3y 2m to grant Granted May 26, 2026

17/912,933

Patent 12629387

COMPOSITION OF ANTIVIRAL AGENT FOR USE IN PROPHYLACTIC OR POST-EXPOSURE TREATMENT OF INFECTIOUS OR RESPIRATORY DISEASES

3y 8m to grant Granted May 19, 2026

18/569,988

Patent 12616778

COMPOSITE ULTRATHIN COATING FILM WITH INHIBITORY ACTIVITY AGAINST HYPERINFLAMMATORY RESPONSE AND BACTERIA, IMPLANT INCLUDING SAME, AND PREPARATION METHOD THEREFOR

2y 4m to grant Granted May 05, 2026

17/791,799

Patent 12606589

BRIDGED NUCLEOSIDE AND NUCLEOTIDE USING SAME

3y 9m to grant Granted Apr 21, 2026

18/602,969

Patent 12605397

DEOXY-CYTIDINE OR URIDINE DERIVATIVES FOR USE IN CANCER THERAPIES

2y 1m to grant Granted Apr 21, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

74%

Grant Probability

89%

With Interview (+14.5%)

2y 3m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 1146 resolved cases by this examiner. Grant probability derived from career allowance rate.